FÓSFORO 15-30 MAX B

Mineralizing action, restorative tonic
Phosphorus, glucose, B complex vitamins
Injectable use
50 ml and 100 ml bottle

Composition: each 100 ml contains: Monosodium phosphate 21.6 g, Disodium phosphate 450 mg, Glucose 10 g, Vitamin B1 50 mg, Vitamin B2 25 mg, Vitamin B6 100 mg, Vitamin B12 5 mg.
Indications: restorative tonic, vitamins. Prevention and control of hypophosphatemia.
Cattle: treatment of downer cow syndrome caused by hypophosphatemia. Supportive treatment of puerperal hypocalcemia and hypocalcemic tetany. Treatment of postpartum negative energy balance. Treatment of agalactia caused by phosphorus imbalance. Treatment of hemolytic anemia due to erythrocyte fragility in anaplasmosis or piroplasmosis. Coxo-femoral osteochondrosis syndrome, articular pathologies due to chronic hypophosphatemia.

Horses: stimulation of the enzymatic activity of the glycolytic pathways accelerating the formation of ATP, enhancement of anaerobic glycolysis activity. Amelioration of energy metabolism producing an improvement in exercise performance, health and reproduction. It replenishes and maintains phosphocreatine as a source for anaerobic ATP production.

South American camelids, sheep, pigs and goats: fertility improvement in females and males in the breeding season (natural service or artificial insemination), lessening of transport stress and climate change effects, enhancement of hematopoiesis and immunity levels and resistance against various diseases, stimulation of nerve tissue regeneration, improvement of liver function, increased milk production, enhancement of weight gain, benefiting hair and wool production of optimum quality.

Poultry: improvement of energy metabolism, increased resistance to extreme conditions, reduction of transport stress and climate change effects. Improvement of the molting process, fertility, egg laying and quality of feathers and eggs.

Administration and dosage: by slow intravenous (IV) infusion or intramuscular (IM) route.
Cattle: Indicative dose: 10 ml by IM route.

Alert downer cows:
– Preventive dose: 10 ml by IM route, 15 to 20 days before delivery.
– Therapeutic dose: administer 100 ml diluted into 400 ml of Power Shock by slow IV infusion. If necessary, it is possible to repeat the treatment 12 hours after the first dose.

Improvement of reproductive efficiency: At the end of the period between delivery and the first service (ideally, after 40 days postpartum): 10 ml by IM route. In cases of ovarian atrophy of nutritional origin, repeat after 30 days.
Supportive treatment in ketotic syndrome, hepatic coma with hyperammonemia and negative energy balance in the immediate postpartum period: 100 ml diluted into 400 ml of Power Shock by slow IV infusion.
Supportive treatment of puerperal hypocalcemia and hypocalcemic tetany: if after the usual treatment, a cow maintains a state of paresis or weakness in the hindquarters, administer 100 ml diluted into 400 ml of Power Shock by slow IV infusion. If necessary, it is possible to repeat the treatment 12 hours after the first dose.

Horses:
Improvement of reproductive efficiency: 10 ml by IV route, repeat every week during the breeding season, until completing five injections. The treatment is complementary to hormonal therapy.
Prophylaxis of muscle fatigue, as an activator of ATP synthesis, in sport horses: 10 ml by IV route and repeat the treatment every 48 hours for a total of five administrations. In sport horses, the treatment should be suspended two days before a competition.
Therapeutics for degenerative myopathy and rhabdomyolysis: administer 20 ml diluted into 400 ml of Power Shock by slow IV infusion. Repeat every 24 hours for five days. This treatment is compatible with other therapeutics for these pathologies.

South American camelids, sheep, pigs and goats:
Camelids: 8 to 10 ml by IM route, repeat after a week if necessary.
Sheep, pigs and goats: 5 ml by IM route, repeat after a week if necessary.
Poultry: Administer 0.5 to 1 ml per bird and repeat according to professional criteria.
Administer according to professional criteria.